Fulcrum Therapeutics, Inc.
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2020 | $347.99 |
| FY2021 | $541.92 |
| FY2022 | $140.96 |
| FY2023 | $45.75 |
| FY2024 | $1,290.66 |
| FY2025 | $0.00 |
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2020 | $347.99 |
| FY2021 | $541.92 |
| FY2022 | $140.96 |
| FY2023 | $45.75 |
| FY2024 | $1,290.66 |
| FY2025 | $0.00 |